Spontaneous uterine activity during the oestrous cycle of the camel (Camelus dromedarius)

Camel Research Centre, College of Veterinary Medicine and Animal Resources, King Faisal University, P.O. Box 1757, Al-Ahsa 31982, Saudi Arabia
Animal Reproduction Science (Impact Factor: 1.51). 07/1993; 32(1-2):91-97. DOI: 10.1016/0378-4320(93)90060-5


Spontaneous uterine activity was studied in three cyclical female camels implanted with balloon-tipped catheters connected to pressure transducers. Another camel was not operated upon. The frequency of contractions in both horns varied from zero to a maximum of 90 h−1, whereas the amplitude of contractions varied from zero to a maximum of 3.5 kPa during the experimental period. Uterine activity was higher in the left horn. Concentrations of oestradiol-17β increased as the follicle grew in size in the non-operated camel. The pattern of uterine activity was correlated with the circulating levels of oestradiol-17β (r=0.83, P<0.001, n=3). It was concluded that uterine activity in the camel is dependent on oestrogen level.

2 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: Bilateral ovariectomy was performed in three parous, non-pregnant camels. Intrauterine and intraabdominal pressure changes were recorded using balloon-tipped catheters. Uterine contractions were induced and maintained in the ovariectomized camels by daily intramuscular injections of 5 mg oestradiol benzoate throughout the experimental period. The frequency of uterine contractions varied from 6 to 9 per minute, whereas the amplitude varied from 2 to 3 kPa in all the animals. Inducing hypocalcaemia to a level of 0.5 mmol/L by Na2EDTA reduced the amplitude of the contractions to below 1 kPa (p < 0.001). The frequency of the contractions was not affected.
    Veterinary Research Communications 02/1997; 21(1):45-50. DOI:10.1023/B:VERC.0000009700.44186.99 · 1.24 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Reproductive losses in camelids are due to infertility, pregnancy loss, udder diseases and neonatal mortality caused by a variety of infectious diseases. Uterine infection and abortion represent the major complaint in camelid veterinary practice. The major infectious organisms in endometritis and metritis are E. coli and Streptococcus equi subspecies zooepidemicus. Abortion rates due to infectious diseases vary from 10% to more than 70% in some areas. Leptospirosis, toxoplasmosis and chlamydiosis have been diagnosed as the major causes of abortion in llamas and alpacas. In camels, brucellosis and trypanosomiasis represent the major causes of infectious abortion in the Middle East and Africa. Mastitis is rare in South American camelids. The prevalence of subclinical udder infection in camels can reach very high proportions in dairy camels. Udder infections are primarily due to Streptococcus agalactiae and Staphylococcus aureus. Neonatal mortality is primarily due to diarrhea following failure of passive transfer and exposure to E. coli, rotavirus, coronavirus, Coccidia and Salmonella. This paper reviews the etio-pathogenesis of these causes of reproductive losses, as well as the major risk factors and strategies to prevent their occurrence.
    Theriogenology 09/2006; 66(3):633-47. DOI:10.1016/j.theriogenology.2006.04.008 · 1.80 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Sections of camel uterus stained with immunoperoxidase for demonstration of estrogen and progesterone receptors showed that receptors for the two hormones were confined to epithelial nuclei. Staining intensity was stronger for progesterone receptors during estrus and pregnancy but weaker for estrogen receptors during pregnancy. In ovariectomized camels intramuscular administration of estradiol benzoate at a dose of 5 mg animal -1 increased uterine progesterone and estrogen receptor concentrations. Administration of progesterone at a dose of 100 mg per animal decreased steroid receptor concentrations. It is suggested that in the camel, uterine steroid receptors are up-regulated by estradiol and down-regulated by progesterone.
    01/2010; 4(1):5-8. DOI:10.3923/rjpharm.2010.5.8